BMJ Open Respiratory Research (Nov 2023)

Prevalence and clinical characteristics of non-malignant CT detected incidental findings in the SUMMIT lung cancer screening cohort

  • ,
  • Anthony Edey,
  • Neal Navani,
  • Andrew W Creamer,
  • Kitty Chan,
  • Graham Robinson,
  • Janine Zylstra,
  • Paul Robinson,
  • Laura Green,
  • Anand Devaraj,
  • Jane Rowlands,
  • Allan Hackshaw,
  • Carolyn Horst,
  • Arjun Nair,
  • Sam M Janes,
  • Kate Davies,
  • Jeannie Eng,
  • Mamta Ruparel,
  • Samantha L Quaife,
  • Jennifer L Dickson,
  • Magali Taylor,
  • Angshu Bhowmik,
  • Karen Sennett,
  • Samantha Quaife,
  • Samuel Janes,
  • Hasti Robbie,
  • Joseph Jacob,
  • Laura Farrelly,
  • Sophie Tisi,
  • Andrew Creamer,
  • Helen Hall,
  • Samanjit Hare,
  • Jon Teague,
  • Thea Buchan,
  • Stephen Ellis,
  • Thomas Callender,
  • Rachael Sarpong,
  • John McCabe,
  • Zaheer Mangera,
  • Ethaar El-Emir,
  • Terry O'Shaughnessy,
  • Nick Screaton,
  • Priyam Verghese,
  • William M Ricketts,
  • Anne-Marie Mullin,
  • Vicky Bowyer,
  • Kylie Gyertson,
  • Fanta Bojang,
  • Claire Levermore,
  • Ruth Prendecki,
  • Amyn Bhamani,
  • Malavika Suresh,
  • Judy Airebamen,
  • Alice Cotton,
  • Kaylene Phua,
  • Elodie Murali,
  • Simranjit Mehta,
  • Karen Parry-Billings,
  • Columbus Ife,
  • April Neville,
  • Zahra Hanif,
  • Helen Kiconco,
  • Ricardo McEwen,
  • Dominique Arancon,
  • Nicholas Beech,
  • Derya Ovayolu,
  • Christine Hosein,
  • Sylvia Patricia Enes,
  • Qin April Neville,
  • Aashna Samson,
  • Urja Patel,
  • Fahmida Hoque,
  • Hina Pervez,
  • Sofia Nnorom,
  • Moksud Miah,
  • Julian McKee,
  • Mark Clark,
  • Anant Patel,
  • Sara Lock,
  • Rajesh Banka,
  • Ugo Ekeowa,
  • Charlotte Cash,
  • Tunku Aziz,
  • Alberto Villanueva,
  • Elena Stefan,
  • Charlie Sayer,
  • Navinah Nundlall,
  • Lyndsey Gallagher,
  • Andrew Crossingham,
  • Tanita Limani,
  • Kate Gowers,
  • James Rusius,
  • Jennifer Dickson,
  • Anne-Marie Hacker,
  • Jonathon Teague,
  • Andrew Perugia TaniaAnastasiadis

DOI
https://doi.org/10.1136/bmjresp-2023-001664
Journal volume & issue
Vol. 10, no. 1

Abstract

Read online

Background Pulmonary and extrapulmonary incidental findings are frequently identified on CT scans performed for lung cancer screening. Uncertainty regarding their clinical significance and how and when such findings should be reported back to clinicians and participants persists. We examined the prevalence of non-malignant incidental findings within a lung cancer screening cohort and investigated the morbidity and relevant risk factors associated with incidental findings. We quantified the primary and secondary care referrals generated by our protocol.Methods The SUMMIT study (NCT03934866) is a prospective observational cohort study to examine the performance of delivering a low-dose CT (LDCT) screening service to a high-risk population. Spirometry, blood pressure, height/weight and respiratory history were assessed as part of a Lung Health Check. Individuals at high risk of lung cancer were offered an LDCT and returned for two further annual visits. This analysis is a prospective evaluation of the standardised reporting and management protocol for incidental findings developed for the study on the baseline LDCT.Results In 11 115 participants included in this analysis, the most common incidental findings were coronary artery calcification (64.2%) and emphysema (33.4%). From our protocolised management approach, the number of participants requiring review for clinically relevant findings in primary care was 1 in 20, and the number potentially requiring review in secondary care was 1 in 25.Conclusions Incidental findings are common in lung cancer screening and can be associated with reported symptoms and comorbidities. A standardised reporting protocol allows systematic assessment and standardises onward management.